Mast cell and eosinophil surface receptors as targets for anti-allergic therapy

Pharmacol Ther. 2017 Feb:170:37-63. doi: 10.1016/j.pharmthera.2016.10.010. Epub 2016 Oct 20.

Authors

Roopesh Singh Gangwar¹, Nadine Landolina¹, Ludovica Arpinati¹, Francesca Levi-Schaffer²

Affiliations

¹ Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel.
² Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel. Electronic address: francescal@ekmd.huji.ac.il.

PMID: 27773785
DOI: 10.1016/j.pharmthera.2016.10.010

No abstract available

Keywords: Activating receptors; Allergy; Anti-allergic therapy; Eosinophils; Inhibitory receptors; Mast cells.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Anti-Allergic Agents / pharmacology*
Eosinophils / drug effects*
Eosinophils / metabolism*
Humans
Hypersensitivity / drug therapy*
Hypersensitivity / metabolism
Ligands
Mast Cells / drug effects*
Mast Cells / metabolism*
Receptors, Cell Surface / metabolism*

Substances

Anti-Allergic Agents
Ligands
Receptors, Cell Surface